Cargando…

PARP inhibitor shuts down the global translation of thyroid cancer through promoting Pol II binding to DIMT1 pause

Thyroid cancer has become the most frequent endocrine-related malignancy. Currently, a mounting body of evidences support the clinical strategies for extending the benefit of PARP inhibitors beyond BRCA-mutant cancers. However, the functions and molecular mechanisms of PARP inhibitors in thyroid can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Xiukun, Tian, Mengran, Ning, Junya, Wang, Zhongyu, Guo, Fengli, Zhang, Wei, Hu, Linfei, Wei, Songfeng, Hu, Chuanxiang, Yun, Xinwei, Zhao, Jingzhu, Dong, Qiman, Ruan, Xianhui, Li, Dapeng, Gao, Ming, Zheng, Xiangqian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411462/ https://www.ncbi.nlm.nih.gov/pubmed/37564214 http://dx.doi.org/10.7150/ijbs.81895

Ejemplares similares

LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma
por: Hou, Xiukun, et al.
Publicado: (2021)

Aurora kinase a promotes the progression of papillary thyroid carcinoma by activating the mTORC2-AKT signalling pathway
por: Zhao, Zewei, et al.
Publicado: (2022)

To Explore the Inhibitory Mechanism of Quercetin in Thyroid Papillary Carcinoma through Network Pharmacology and Experiments
por: Sun, Ying, et al.
Publicado: (2022)

Apatinib Inhibits Cell Proliferation and Induces Autophagy in Human Papillary Thyroid Carcinoma via the PI3K/Akt/mTOR Signaling Pathway
por: Meng, Xiangrui, et al.
Publicado: (2020)

Coupling of co-transcriptional splicing and 3’ end Pol II pausing during termination in Arabidopsis
por: Zhou, Sixian, et al.
Publicado: (2023)

Early Combined SHP2 Targeting Reverses the Therapeutic Resistance of Vemurafenib in Thyroid Cancer
por: Ma, Weike, et al.
Publicado: (2023)

Regulation of Pol II Pausing during Daily Gene Transcription in Mouse Liver
por: Xu, Wei, et al.
Publicado: (2023)

SAYP and Brahma are important for ‘repressive’ and ‘transient’ Pol II pausing
por: Vorobyeva, Nadezhda E., et al.
Publicado: (2012)

Dynamic turnover of paused Pol II complexes at human promoters
por: Erickson, Benjamin, et al.
Publicado: (2018)

Structure of paused transcription complex Pol II-DSIF-NELF
por: Vos, Seychelle M., et al.
Publicado: (2018)

Identification of potential pathogenic candidates or diagnostic biomarkers in papillary thyroid carcinoma using expression and methylation profiles
por: Wei, Songfeng, et al.
Publicado: (2019)

BRMS1 downregulation is a poor prognostic biomarker in anaplastic thyroid carcinoma patients
por: Wu, Yu, et al.
Publicado: (2019)

Pharmacological inhibition of Ref-1 enhances the therapeutic sensitivity of papillary thyroid carcinoma to vemurafenib
por: Hu, Linfei, et al.
Publicado: (2022)

Genome-wide RNA pol II initiation and pausing in neural progenitors of the rat
por: Scheidegger, Adam, et al.
Publicado: (2019)

Release of promoter–proximal paused Pol II in response to histone deacetylase inhibition
por: Vaid, Roshan, et al.
Publicado: (2020)

RNA Pol II pausing facilitates phased pluripotency transitions by buffering transcription
por: Abuhashem, Abderhman, et al.
Publicado: (2022)

Noncatalytic regulation of 18S rRNA methyltransferase DIMT1 in acute myeloid leukemia
por: Gonskikh, Yulia, et al.
Publicado: (2023)

Preoperative supplementation of calcitriol and calcium relieves symptom and extent of hypocalcemia in patients undergoing total thyroidectomy and bilateral central compartment neck dissection: A prospective, randomized, open-label, parallel-controlled clinical study
por: Li, Dapeng, et al.
Publicado: (2022)

Enhancer RNAs stimulate Pol II pause release by harnessing multivalent interactions to NELF
por: Gorbovytska, Vladyslava, et al.
Publicado: (2022)

The mechanisms of celastrol in treating papillary thyroid carcinoma based on network pharmacology and experiment verification
por: Yi, Jiaoyu, et al.
Publicado: (2021)

Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: a study of 1,587 patients
por: Zheng, Xiangqian, et al.
Publicado: (2019)

Human DIMT1 generates N(2)(6,6)A-dimethylation–containing small RNAs
por: Shen, Hui, et al.
Publicado: (2021)

Oxidative stress rapidly stabilizes promoter-proximal paused Pol II across the human genome
por: Nilson, Kyle A., et al.
Publicado: (2017)

BORDER proteins protect expression of neighboring genes by promoting 3′ Pol II pausing in plants
por: Yu, Xuhong, et al.
Publicado: (2019)

Evidence of slightly increased Pol II pausing in UPF1-depleted Drosophila melanogaster cells
por: Singh, Anand K, et al.
Publicado: (2020)

KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt/β-catenin signaling pathway
por: Zhang, Wei, et al.
Publicado: (2022)

Hypoxia‐inducible microRNA‐210 regulates the DIMT1‐IRF4 oncogenic axis in multiple myeloma
por: Ikeda, Sho, et al.
Publicado: (2017)

Ribosomal biogenesis regulator DIMT1 controls β-cell protein synthesis, mitochondrial function, and insulin secretion
por: Verma, Gaurav, et al.
Publicado: (2022)

Kinetics of promoter Pol II on Hsp70 reveal stable pausing and key insights into its regulation
por: Buckley, Martin S., et al.
Publicado: (2014)

Genome-wide dynamics of Pol II elongation and its interplay with promoter proximal pausing, chromatin, and exons
por: Jonkers, Iris, et al.
Publicado: (2014)

Integrated microRNA-mRNA analyses of distinct expression profiles in follicular thyroid tumors
por: Chi, Jiadong, et al.
Publicado: (2017)

High expression of NUCB2 promotes papillary thyroid cancer cells proliferation and invasion
por: Zhao, Jingzhu, et al.
Publicado: (2019)

Integrator is recruited to promoter‐proximally paused RNA Pol II to generate Caenorhabditis elegans piRNA precursors
por: Beltran, Toni, et al.
Publicado: (2020)

Lola-I is a promoter pioneer factor that establishes de novo Pol II pausing during development
por: Ramalingam, Vivekanandan, et al.
Publicado: (2023)

Functional analysis and clinical significance of the isocitrate dehydrogenase 2 gene in papillary thyroid carcinoma
por: Zhang, Jun, et al.
Publicado: (2019)

Value of lymph node ratio as a prognostic factor of recurrence in medullary thyroid cancer
por: Hao, Weijing, et al.
Publicado: (2023)

Antitumor effects of anlotinib in thyroid cancer
por: Ruan, Xianhui, et al.
Publicado: (2018)

Targeting Aurora-A inhibits tumor progression and sensitizes thyroid carcinoma to Sorafenib by decreasing PFKFB3-mediated glycolysis
por: Jingtai, Zhi, et al.
Publicado: (2023)

Shut the Door
Publicado: (1874)

Surgery and Radioactive Iodine Therapeutic Strategy for Patients Greater Than 60 Years of Age with Differentiated Thyroid Cancer
por: Tang, Tao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gb1b9aed06agfm8ajip85rh3l9